Yuanjia Zhu1, Annabel M Imbrie-Moore2, Michael J Paulsen3, Bryant Priromprintr4, Hanjay Wang3, Haley J Lucian3, Justin M Farry3, Y Joseph Woo5. 1. Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif; Department of Bioengineering, Stanford University, Stanford, Calif. 2. Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif; Department of Mechanical Engineering, Stanford University, Stanford, Calif. 3. Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif. 4. Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, Calif. 5. Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif; Department of Bioengineering, Stanford University, Stanford, Calif. Electronic address: joswoo@stanford.edu.
Abstract
OBJECTIVE: The objective was to design and evaluate a clinically relevant, novel ex vivo bicuspid aortic valve model that mimics the most common human phenotype with associated aortic regurgitation. METHODS: Three bovine aortic valves were mounted asymmetrically in a previously validated 3-dimensional-printed left heart simulator. The non-right commissure and the non-left commissure were both shifted slightly toward the left-right commissure, and the left and right coronary cusps were sewn together. The left-right commissure was then detached and reimplanted 10 mm lower than its native height. Free margin shortening was used for valve repair. Hemodynamic status, high-speed videography, and echocardiography data were collected before and after the repair. RESULTS: The bicuspid aortic valve model was successfully produced and repaired. High-speed videography confirmed prolapse of the fused cusp of the baseline bicuspid aortic valve models in diastole. Hemodynamic and pressure data confirmed accurate simulation of diseased conditions with aortic regurgitation and the subsequent repair. Regurgitant fraction postrepair was significantly reduced compared with that at baseline (14.5 ± 4.4% vs 28.6% ± 3.4%; P = .037). There was no change in peak velocity, peak gradient, or mean gradient across the valve pre- versus postrepair: 293.3 ± 18.3 cm/sec versus 325.3 ± 58.2 cm/sec (P = .29), 34.3 ± 4.2 mm Hg versus 43.3 ± 15.4 mm Hg (P = .30), and 11 ± 1 mm Hg versus 9.3 ± 2.5 mm Hg (P = .34), respectively. CONCLUSIONS: An ex vivo bicuspid aortic valve model was designed that recapitulated the most common human phenotype with aortic regurgitation. These valves were successfully repaired, validating its potential for evaluating valve hemodynamics and optimizing surgical repair for bicuspid aortic valves.
OBJECTIVE: The objective was to design and evaluate a clinically relevant, novel ex vivo bicuspid aortic valve model that mimics the most common human phenotype with associated aortic regurgitation. METHODS: Three bovine aortic valves were mounted asymmetrically in a previously validated 3-dimensional-printed left heart simulator. The non-right commissure and the non-left commissure were both shifted slightly toward the left-right commissure, and the left and right coronary cusps were sewn together. The left-right commissure was then detached and reimplanted 10 mm lower than its native height. Free margin shortening was used for valve repair. Hemodynamic status, high-speed videography, and echocardiography data were collected before and after the repair. RESULTS: The bicuspid aortic valve model was successfully produced and repaired. High-speed videography confirmed prolapse of the fused cusp of the baseline bicuspid aortic valve models in diastole. Hemodynamic and pressure data confirmed accurate simulation of diseased conditions with aortic regurgitation and the subsequent repair. Regurgitant fraction postrepair was significantly reduced compared with that at baseline (14.5 ± 4.4% vs 28.6% ± 3.4%; P = .037). There was no change in peak velocity, peak gradient, or mean gradient across the valve pre- versus postrepair: 293.3 ± 18.3 cm/sec versus 325.3 ± 58.2 cm/sec (P = .29), 34.3 ± 4.2 mm Hg versus 43.3 ± 15.4 mm Hg (P = .30), and 11 ± 1 mm Hg versus 9.3 ± 2.5 mm Hg (P = .34), respectively. CONCLUSIONS: An ex vivo bicuspid aortic valve model was designed that recapitulated the most common human phenotype with aortic regurgitation. These valves were successfully repaired, validating its potential for evaluating valve hemodynamics and optimizing surgical repair for bicuspid aortic valves.
Authors: Elizabeth H Stephens; Thomas A Hope; Fabian A Kari; John-Peder Escobar Kvitting; David H Liang; Robert J Herfkens; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2015-04-10 Impact factor: 5.209
Authors: Michael J Paulsen; Patpilai Kasinpila; Annabel M Imbrie-Moore; Hanjay Wang; Camille E Hironaka; Tiffany K Koyano; Robyn Fong; Peter Chiu; Andrew B Goldstone; Amanda N Steele; Lyndsay M Stapleton; Michael Ma; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2018-11-15 Impact factor: 5.209
Authors: Paul N Jermihov; Lu Jia; Michael S Sacks; Robert C Gorman; Joseph H Gorman; Krishnan B Chandran Journal: Cardiovasc Eng Technol Date: 2011-03 Impact factor: 2.495
Authors: Annabel M Imbrie-Moore; Cole C Paullin; Michael J Paulsen; Frederick Grady; Hanjay Wang; Camille E Hironaka; Justin M Farry; Haley J Lucian; Y Joseph Woo Journal: Med Eng Phys Date: 2020-01-31 Impact factor: 2.242
Authors: Yuanjia Zhu; Mateo Marin-Cuartas; Matthew H Park; Annabel M Imbrie-Moore; Robert J Wilkerson; Sarah Madira; Danielle M Mullis; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2021-09-16 Impact factor: 5.209
Authors: Luca Rosalia; Caglar Ozturk; Jaume Coll-Font; Yiling Fan; Yasufumi Nagata; Manisha Singh; Debkalpa Goswami; Adam Mauskapf; Shi Chen; Robert A Eder; Efrat M Goffer; Jo H Kim; Salva Yurista; Benjamin P Bonner; Anna N Foster; Robert A Levine; Elazer R Edelman; Marcello Panagia; Jose L Guerrero; Ellen T Roche; Christopher T Nguyen Journal: Nat Biomed Eng Date: 2022-09-26 Impact factor: 29.234
Authors: Yuanjia Zhu; Annabel M Imbrie-Moore; Michael J Paulsen; Matthew H Park; Nicholas A Tran; Y Joseph Woo Journal: Ann Thorac Surg Date: 2022-02-22 Impact factor: 5.102
Authors: Michael J Paulsen; Mateo Marin Cuartas; Annabel Imbrie-Moore; Hanjay Wang; Robert Wilkerson; Justin Farry; Yuanjia Zhu; Michael Ma; John W MacArthur; Y Joseph Woo Journal: JTCVS Tech Date: 2021-10-07
Authors: Mateo Marin-Cuartas; Yuanjia Zhu; Annabel M Imbrie-Moore; Matthew H Park; Robert J Wilkerson; Matthew Leipzig; Pearly K Pandya; Michael J Paulsen; Michael A Borger; Y Joseph Woo Journal: Interact Cardiovasc Thorac Surg Date: 2022-05-02
Authors: Matthew H Park; Yuanjia Zhu; Annabel M Imbrie-Moore; Hanjay Wang; Mateo Marin-Cuartas; Michael J Paulsen; Y Joseph Woo Journal: Front Cardiovasc Med Date: 2021-07-08